Calendar Alnylam Pharmaceuticals, Inc.

Equities

ALNY

US02043Q1076

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 20:59:23 18/06/2025 BST			5-day change	1st Jan Change
312.09 ^USD	+1.09%		+4.52%	+32.63%

06-18	Alnylam Announces Promotion of Pushkal Garg as Executive Vice President and Chief Research and Development Officer	CI
06-09	Alnylam Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 09:20 AM

Chart calendar Alnylam Pharmaceuticals, Inc.

2e0c0d8454063e946065c693ebd.mv5nvVfWA7BIbDBuxS5i3y3WT9biJFgWYU4gYHJsm1w.1LEM7xWTVtMjWntc8UUTqRSvPJSBFwAgCBFpMSMb4x23nR-NFphT_zIcRw~67b43a104e236690a56ae781191a12e3

Upcoming events on Alnylam Pharmaceuticals, Inc.

30/07/2025	Q2 2025 Earnings Release (Projected)
22/10/2025	Q3 2025 Earnings Release (Projected)
11/02/2026	Q4 2025 Earnings Release (Projected)
29/04/2026	Q1 2026 Earnings Release (Projected)

Past events on Alnylam Pharmaceuticals, Inc.

09/06/2025 14:20	Goldman Sachs Global Healthcare Conference
20/05/2025 08:21	European Society of Cardiology Heart Failure Congress
19/05/2025 13:00	European Society of Cardiology Heart Failure Congress
19/05/2025 08:00	European Society of Cardiology Heart Failure Congress
18/05/2025 12:00	European Society of Cardiology Heart Failure Congress
17/05/2025 10:50	European Society of Cardiology Heart Failure Congress
14/05/2025 19:20	Bank of America Global Healthcare Conference
08/05/2025 13:30	Annual General Meeting
01/05/2025 13:30	Q1 2025 Earnings Call
01/05/2025 13:00	Q1 2025 Earnings Release
08/04/2025 16:45	Needham Healthcare Conference
20/03/2025 22:00	AMVUTTRA® FDA Approval Call
18/03/2025 19:00	Stifel Virtual CNS Forum
25/02/2025 14:00	R&D Day
13/02/2025 13:30	Q4 2024 Earnings Call
13/02/2025 13:00	Q4 2024 Earnings Release
13/01/2025 17:45	JP Morgan Healthcare Conference
05/12/2024 16:00	Piper Sandler Healthcare Conference
20/11/2024 09:30	Jefferies London Healthcare Conference
12/11/2024 16:44	UBS Global Healthcare Conference

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	1 037 1 013 2.41%	1 828 1 827 0.1%	2 248 2 235 0.57%	2 899	3 783	4 903
EBITDA Million USD	Released Forecast Spread	-741 -646 -14.71%	-228 -250 8.91%	-120 -66,4 -81.11%	64,4	772	1 981
EBIT Million USD	Released Forecast Spread	-785 -813 3.38%	-282 -275 -2.6%	-177 -127 -39.16%	18,6	325	1 033
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-1 127 -1 138 1%	-434 -437 0.72%	-377 -254 -48.31%	-150	154	941
Net income Million USD	Released Forecast Spread	-1 131 -1 156 2.16%	-440 -441 0.12%	-278 -257 -8.18%	-154	169	833
EPS USD	Released Forecast Spread	-9,30 -9,42 1.32%	-3,52 -3,53 0.29%	-2,18 -2,01 -8.49%	-1,12	1,46	6,18
Announcement Date		23/02/23	15/02/24	13/02/25	-

Quarterly results

Fiscal Period	March	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	751 395 90.22%	440 442 -0.58%	494 427 15.84%	660 444 48.56%	501 527 -4.95%	593 581 2.16%	594 581 2.23%	628	725	934	963	1 078	1 165	1 334
EBITDA Million USD	Released Forecast Spread	227 -134 269.42%	-103 -143 28.23%	-29,9 -123 75.76%	63,6 -115 155.56%	-62,9 -82,7 23.91%	-91,0 -56,1 -62.19%	32,5 -107 130.36%	-35,7	-43,9	105
EBIT Million USD	Released Forecast Spread	214 -165 229.79%	-116 -114 -2.24%	-43,4 -117 63.03%	48,6 -114 142.58%	-76,9 -98,9 22.24%	-105 -57,2 -83.86%	18,1 -102 117.8%	-63,4	-15,2	78,4	-29,4	17,0	54,7	161
Earnings before Tax (EBT) Million USD	Released Forecast Spread	151 -206 173.12%	-138 -149 7.5%	-63,6 -133 52.26%	-11,2 -136 91.8%	-109 -123 11.85%	-194 -67,0 -189.64%	-41,6 -130 67.91%	-96,4	-36,4	33,6	-47,9	-10,8	8,72	105
Net income Million USD	Released Forecast Spread	148 -184 180.46%	-138 -157 12.18%	-65,9 -144 54.13%	-16,9 -135 87.49%	-112 -123 9.38%	-83,8 -80,0 -4.69%	-57,5 -121 52.4%	-94,2	-52,8	36,5	-50,6	-13,8	5,47	102
EPS USD	Released Forecast Spread	1,18 -1,47 180.25%	-1,10 -1,25 11.8%	-0,52 -1,17 55.39%	-0,13 -1,09 88.09%	-0,87 -0,94 7.71%	-0,65 -0,59 -10.22%	-0,44 -1,01 56.22%	-0,79	-0,50	0,51	-0,28	-0,02	0,23	0,73
Announcement Date		02/11/23	15/02/24	02/05/24	01/08/24	31/10/24	13/02/25	01/05/25	-	-	-	-	-	-	-

Upcoming sector events for Alnylam Pharmaceuticals, Inc.

09/07/2025	HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
15/07/2025	GLAND PHARMA LIMITED: Q1 2026 Earnings Release (Projected)
16/07/2025 11:45	JOHNSON & JOHNSON: Q2 2025 Earnings Release
16/07/2025	NOVARTIS AG: Q2 2025 Earnings Release
16/07/2025	CAMURUS AB: Q2 2025 Earnings Release
17/07/2025	JUBILANT PHARMOVA LIMITED: Q1 2026 Earnings Release (Projected)
18/07/2025 10:00	ORION OYJ: Q2 2025 Earnings Release
22/07/2025	LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q2 2025 Earnings Release (Projected)
22/07/2025	TILRAY BRANDS, INC.: Q4 2025 Earnings Release (Projected)
22/07/2025	GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q2 2025 Earnings Release (Projected)

More events

Past sector events for Alnylam Pharmaceuticals, Inc.

17/06/2025 16:45	MEDINCELL S.A.: Q4 2025 Earnings Release
10/06/2025 09:38	LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release
09/06/2025 09:48	YUNGSHIN GLOBAL HOLDING CORPORATION: May 2025 Sales and Revenue Release
09/06/2025 01:01	BORA PHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release
06/06/2025 09:47	CALIWAY BIOPHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release
05/06/2025 09:37	TTY BIOPHARM COMPANY LIMITED: May 2025 Sales and Revenue Release
03/06/2025 09:35	ONENESS BIOTECH CO., LTD.: May 2025 Sales and Revenue Release
30/05/2025 14:46	ASTRAZENECA PHARMA INDIA LIMITED: Q4 2025 Earnings Release
29/05/2025 12:00	ROIVANT SCIENCES LTD.: Q4 2024 Earnings Release
29/05/2025 09:31	ALKEM LABORATORIES LIMITED: Q4 2025 Earnings Release